My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Bayer to acquire Monsanto in all cash transaction

Bayer to acquire Monsanto in all cash transaction

Sep 14,2016

Monsanto India announced that Bayer and Monsanto signed definitive agreement under which Bayer will acquire Monsanto for USD 128 per share in an all cash transaction.

Powered by Capital Market - Live News

JK Agri Genetics announces change in website
Jul 20,2017

JK Agri Genetics announced the change in the company website from www.jkseeds.net to www.jkagri.com.

Powered by Capital Market - Live News

Sugar stocks spurt on spike in sugar prices on the NCDEX
Jul 20,2017

Meanwhile, the S&P BSE Sensex was down 59.43 points or 0.19% at 31,895.92.

Triveni Engineering & Industries (up 8.4%), Shree Renuka Sugars (up 7%), Sakthi Sugars (up 4.41%), Dhampur Sugar Mills (up 4.03%), Rana Sugars (up 3.7%), Dwarikesh Sugar Industries (up 2.74%), Bajaj Hindusthan Sugar (up 2.66%), Balrampur Chini Mills (up 1.98%) and KCP Sugar & Industries (up 1.61%) surged.

Recently, the Government of India had hiked import duty on sugar to 50% from 40% with effect from 10 July 2017, to restrict cheap inward shipments and maintain domestic prices.

Also, the demand for sugar is expected to rise as the festive season is around the corner.

Powered by Capital Market - Live News

Cabinet approves alternative mechanism for creation and launch of a New Exchange Traded Fund
Jul 20,2017

The Cabinet Committee on Economic Affairs, chaired by the Prime Minister Shri Narendra Modi has authorized the Alternative Mechanism on the following:

i. To take decision for divestment through Exchange Traded Fund (ETF) out of all the listed CPSEs including CPSEs listed subsequently subject to GoI retaining 51% in these CPSEs;

ii. To take decision on the divestment in respect of Public Sector Banks, other listed Public Sector Financial Institutions and Public Sector Insurance Companies (when listed) through ETF or other methods subject to GoI retaining 52%; and

iii. To take decision on matters related to divestment through ETF like constitution of ETF portfolio; the price/net asset value at which share of listed companies forming the ETF basket will be placed by the Govt. for divestment at the disposal of the ETF provider (AMC); the incentive structure for investors - upfront discount, loyalty bonus etc.; and any other aspect of pricing and the mode of disinvestment as required to be taken by the Government.

Powered by Capital Market - Live News

Natco Pharma in pink of health after USFDA clears facility
Jul 20,2017

The announcement was made during market hours today, 20 July 2017.

Meanwhile, the S&P BSE Sensex was up 11.68 points or 0.04% at 31,967.03.

On the BSE, 35,047 shares were traded on the counter so far as against the average daily volumes of 55,893 shares in the past one quarter. The stock had hit a high of Rs 1,027.45 and a low of Rs 1,000 so far during the day. The stock had hit a record high of Rs 1,080 on 9 June 2017 and a 52-week low of Rs 495 on 9 November 2016.

The stock had underperformed the market over the past one month till 19 July 2017, gaining 1.99% compared with Sensexs 2.06% rise. The scrip had also underperformed the market in past one quarter, rising 3.55% as against Sensexs 8.93% rise. The scrip had, however, outperformed the market in past one year, gaining 70.57% as against Sensexs 15% rise.

The large-cap company has equity capital of Rs 34.86 crore. Face value per share is Rs 2.

Natco Pharma announced the receipt of successful Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its drug formulations facility at Kothur unit, Telangana, India, during the period 16 to 24 January 2017.

Kothur formulation facility predominantly caters to regulated international markets, including USA.

Natco Pharmas consolidated net profit spurted 181.4% to Rs 176.70 crore on 46.5% increase in net sales to Rs 577.80 crore in Q4 March 2017 over Q4 March 2016.

Natco Pharma manufactures generic dosage forms, bulk actives and intermediates for the Indian and international markets.

Powered by Capital Market - Live News

Board of Sanofi India recommends dividend
Jul 20,2017

Sanofi India announced that the Board of Directors of the Company at its meeting held on 19 July 2017, inter alia, have recommended the dividend of Rs 18 per equity Share (i.e. 180%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Endurance Technologies to hold board meeting
Jul 20,2017

Endurance Technologies will hold a meeting of the Board of Directors of the Company on 8 August 2017, to consider and approve the unaudited financial results for the quarter ended 30th June 2017

Powered by Capital Market - Live News

Bombay Burmah Trading Corporation to table quarterly results
Jul 20,2017

Bombay Burmah Trading Corporation will hold a meeting of the Board of Directors of the Company on 3 August 2017, to inter alia, consider and approve the unaudited financial results of the Corporation for the first quarter ended 30th June 2017.

Powered by Capital Market - Live News

LKP Securities to convene board meeting
Jul 20,2017

LKP Securities will hold a meeting of the Board of Directors of the Company on 4 August 2017, to consider and approve unaudited financial results for the quarter ended 30 June 2017.

Powered by Capital Market - Live News

GPT Infraprojects to hold AGM
Jul 20,2017

GPT Infraprojects announced that the 37th Annual General Meeting (AGM) of the company will be held on 18 August 2017.

Powered by Capital Market - Live News

Ahmedabad Steelcraft schedules AGM
Jul 20,2017

Ahmedabad Steelcraft announced that the Annual General Meeting (AGM) of the company will be held on 4 September 2017.

Powered by Capital Market - Live News

Atlas Cycles advances on stock-split plan
Jul 20,2017

The announcement was made after market hours yesterday, 19 July 2017.

Meanwhile, the S&P BSE Sensex was down 25.47 points, or 0.08% at 31,929.88. The S&P BSE Small-Cap index was up 49.79 points, or 0.31% at 16,024.36.

On the BSE, 436 shares were traded on the counter so far as against the average daily volumes of 3,901 shares in the past one quarter. The stock opened with an upward gap of 5% at Rs 375.05 and remained stuck at that level so far. The stock had hit a record high of Rs 694 on 16 January 2017 and a 52-week low of Rs 195.20 on 12 August 2016.

The stock had underperformed the market over the past one month till 19 July 2017, declining 14.36% compared with the Sensexs 2.06% rise. The scrip had also underperformed the market over the past one quarter declining 16.68% as against the Sensexs 8.93% rise. The scrip had, however, outperformed the market over the past one year advancing 72.23% as against the Sensexs 15% rise.

The small-cap company has equity capital of Rs 3.25 crore. Face value per share is Rs 10.

Atlas Cycles (Haryana) said that a meeting of the board of directors of the company has been scheduled to be held on Friday, 4 August 2017, to consider the sub-division of equity shares of the company.

Atlas Cycles (Haryana) reported net loss of Rs 2.99 crore in Q3 December 2016, compared with net loss of Rs 2.05 crore in Q3 December 2015. Net sales rose 8.5% to Rs 146.75 crore in Q3 December 2016 over Q3 December 2015.

Atlas Cycles (Haryana) is a manufacturer of bicycles. The company manufactures components of bicycles and steel tubes.

Powered by Capital Market - Live News

Jubilant Industries reports consolidated net loss of Rs 1.66 crore in the June 2017 quarter
Jul 20,2017

Net loss of Jubilant Industries reported to Rs 1.66 crore in the quarter ended June 2017 as against net profit of Rs 1.05 crore during the previous quarter ended June 2016. Sales declined 8.64% to Rs 111.17 crore in the quarter ended June 2017 as against Rs 121.69 crore during the previous quarter ended June 2016.

ParticularsQuarter Endedn++Jun. 2017Jun. 2016% Var. Sales111.17121.69 -9 OPM %5.719.89 - PBDT-0.313.26 PL PBT-2.601.07 PL NP-1.661.05 PL

Powered by Capital Market - Live News

Canara Bank standalone net profit rises 9.89% in the June 2017 quarter
Jul 20,2017

Net profit of Canara Bank rose 9.89% to Rs 251.60 crore in the quarter ended June 2017 as against Rs 228.95 crore during the previous quarter ended June 2016. Total Operating Income declined 0.06% to Rs 10195.59 crore in the quarter ended June 2017 as against Rs 10201.70 crore during the previous quarter ended June 2016.

ParticularsQuarter Endedn++Jun. 2017Jun. 2016% Var. Total Operating Income10195.5910201.70 0 OPM %55.3465.04 - PBDT268.60325.95 -18 PBT268.60325.95 -18 NP251.60228.95 10

Powered by Capital Market - Live News

Integra Engineering India standalone net profit declines 47.83% in the June 2017 quarter
Jul 20,2017

Net profit of Integra Engineering India declined 47.83% to Rs 0.24 crore in the quarter ended June 2017 as against Rs 0.46 crore during the previous quarter ended June 2016. Sales rose 15.13% to Rs 9.21 crore in the quarter ended June 2017 as against Rs 8.00 crore during the previous quarter ended June 2016.

ParticularsQuarter Endedn++Jun. 2017Jun. 2016% Var. Sales9.218.00 15 OPM %0.33-0.50 - PBDT0.480.78 -38 PBT0.270.59 -54 NP0.240.46 -48

Powered by Capital Market - Live News

Saboo Brothers standalone net profit rises 25.00% in the June 2017 quarter
Jul 20,2017

Net profit of Saboo Brothers rose 25.00% to Rs 0.05 crore in the quarter ended June 2017 as against Rs 0.04 crore during the previous quarter ended June 2016. There were no Sales reported in the quarter ended June 2017 and during the previous quarter ended June 2016.

Powered by Capital Market - Live News